100 related articles for article (PubMed ID: 7350487)
1. Pros and cons of estrogen-replacement therapy.
Korenman SG
N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350487
[No Abstract] [Full Text] [Related]
2. Pros and cons of estrogen-replacement therapy.
Quigley MM; Hammond CB
N Engl J Med; 1980 Jan; 302(5):297. PubMed ID: 7350488
[No Abstract] [Full Text] [Related]
3. Hormonal replacement therapy--cardiovascular disease.
Silfverstolpe G; Crona N
Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
[No Abstract] [Full Text] [Related]
4. Menopausal hormone replacement therapy in dermatology.
Danby FW
JAMA Dermatol; 2014 Dec; 150(12):1261-2. PubMed ID: 25250584
[No Abstract] [Full Text] [Related]
5. A practical guide to prescribing estrogen replacement therapy.
Corson SL
Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
[TBL] [Abstract][Full Text] [Related]
6. Plausible--yes. But ..
Fenton A; Panay N
Climacteric; 2009 Dec; 12(6):461-2. PubMed ID: 19905898
[No Abstract] [Full Text] [Related]
7. Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin F; Schneider HP; Sturdee DW;
Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
[No Abstract] [Full Text] [Related]
8. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
9. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
10. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
Keller KB; Lemberg L
Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
[No Abstract] [Full Text] [Related]
11. South African Menopause Society Council consensus statement on menopausal hormone therapy.
de Villiers TJ;
S Afr Med J; 2004 Sep; 94(9):760-2. PubMed ID: 15487841
[No Abstract] [Full Text] [Related]
12. [Hormonal substitution after menopause--advantages and risks].
Bengtsson C
Lakartidningen; 1990 Dec; 87(50):4331-3. PubMed ID: 2280638
[No Abstract] [Full Text] [Related]
13. [Possibilities and limitations of hormone therapy between puberty and the menopause].
Kopera H
Munch Med Wochenschr; 1972 Apr; 114(16):754-60. PubMed ID: 5067882
[No Abstract] [Full Text] [Related]
14. Postmenopausal estrogens--opposed, unopposed, or none of the above.
Willett WC; Colditz G; Stampfer M
JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883
[No Abstract] [Full Text] [Related]
15. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
16. Estrogen plus progestin in postmenopausal women--act II.
MacDonald PC
N Engl J Med; 1986 Oct; 315(15):959-61. PubMed ID: 3762597
[No Abstract] [Full Text] [Related]
17. Pros and cons of estrogen-replacement therapy.
Gastel B; Cornoni-Huntley J; Brody JA
N Engl J Med; 1980 Jan; 302(5):296. PubMed ID: 7350484
[No Abstract] [Full Text] [Related]
18. Optimal use of postmenopausal hormone replacement.
Ettinger B
Obstet Gynecol; 1988 Nov; 72(5 Suppl):31S-36S. PubMed ID: 3173939
[TBL] [Abstract][Full Text] [Related]
19. Oral contraception with estrogen and progestin combinations.
Board JA
Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
[No Abstract] [Full Text] [Related]
20. Estrogen use and endometrial cancer.
Sturgis SH
N Engl J Med; 1979 Apr; 300(16):922. PubMed ID: 423942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
